Back to News
Research
We’re still figuring out the side effects of GLP-1 weight-loss drugs
MIT Tech Review·October 9, 2026·1 min read
AI Summary
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age.
From the source
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age. Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar…
The full text couldn't be loaded here (the source may require a subscription).
View original at MIT Tech ReviewKeep reading
The Download: AI’s refusal problem and weight-loss drug side effectsMIT Tech Review · 16h agoWe’re putting too much faith in AI’s ability to say noMIT Tech Review · 20h agoJob titles of the future: Delivery drone air traffic controllerMIT Tech Review · 20h agoRoundtables: A Conversation With the Creator of AI-Designed VirusesMIT Tech Review · 1d ago
Was this useful?